A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Tu Sanfang; Deng Lan; Huang Rui; Zhou Xuan; Yang Jilong; Zhou Weijun; Li Meifang; Yue Chunyan; Wu Shaojie; Guo Zhenling; Chang Lung-Ji; Li Yuhua;

  展开▼
• 作者单位

  Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Genoimmune Med Inst Shenzhen Peoples R China;

  Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词